SB 1389 prohibits healthcare providers participating in Tennessee's TennCare or CoverKids programs from refusing to treat patients solely because they decline vaccines or immunizations. It requires the state to stop reimbursing providers who violate this rule and mandates the TennCare director to create implementing regulations. The law excludes oncology and organ transplant specialists from the prohibition. The bill takes effect July 1, 2025, with rules to be established under state administrative procedures.
SB 1146 requires county medical examiners to test decedents involved in mass shootings (resulting in four or more deaths) for all drugs, including psychotropic medications used for mental health conditions. It mandates anonymized data sharing with the University of Tennessee Health Science Center and the Department of Health, prohibiting disclosure of identifying information. The health science center must study drug interactions and submit quarterly reports to legislative health committees. The law, effective July 1, 2025, applies to medical examiners, health agencies, and the University of Tennessee, while requiring compliance with privacy laws.
SB 955, now known as the "Medical Ethics Defense Act," protects Tennessee healthcare providers from being forced to participate in or pay for medical procedures that conflict with their conscience. It defines "conscience" as sincerely held ethical, moral, or religious beliefs and prohibits discriminatory actions - like termination or penalties - against providers who refuse specific procedures based on those beliefs. The law also safeguards providers who report violations of this act, preventing retaliation for whistleblowing. This applies to healthcare professionals, institutions, and payers but excludes procedures governed by federal law (such as emergency care under EMTALA).
HB 927 clarifies that certain health insurance benefits (like dental or vision coverage, called "excepted benefits") do not need to be included in standard health insurance plans unless state law explicitly requires them. This affects health insurance providers and policyholders in Tennessee by removing an obligation to cover these specific benefits as part of standard coverage. The bill specifies that excepted benefits are exempt from requirements to cover specific people, providers, treatments, or conditions unless mandated by law. It applies to new or renewed insurance policies on or after July 1, 2025.
HB 1198 requires Tennessee health insurers and TennCare to allow patients to try biosimilar drugs (cost-effective copies of brand-name medications) before covering the original branded drug. It amends state law to permit health carriers to mandate a biosimilar trial for equivalent branded prescriptions, removing prior requirements for generic drug trials. The bill also directs TennCare’s pharmacy committee to consider biosimilar drugs when recommending medications for the state’s preferred drug list. These changes aim to reduce prescription drug costs by increasing biosimilar adoption, as stated in the bill’s legislative findings.
HB 37 requires insurers offering health plans to Tennessee state employees to treat FDA-approved non-opioid pain medications equally with opioids on their preferred drug lists (PDL). It prohibits insurers from discouraging coverage for non-opioid options used for pain management, though it allows insurers to prefer one opioid over another or one non-opioid over another. This applies specifically to state employee group insurance plans covered under Tennessee Code Annotated sections 56-7-3801 to 56-7-3803. The law, effective January 1, 2026, aims to expand access to non-opioid pain treatments without mandating their preference.
SB 577 amends Tennessee's TennCare program by shortening the time frame for implementing the annual coverage assessment from seven days to five days. It also establishes limits on hospital payments under specific circumstances, directly affecting TennCare administrators and participating hospitals. The bill changes the timing requirement in Tennessee Code Annotated Section 71-5-2005(d)(2)(D) and became effective April 3, 2025, after being signed by the Governor.
HB 1000 modifies Tennessee's TennCare program by shortening the deadline for implementing the annual coverage assessment from seven to five days. This change directly affects the TennCare program and hospitals receiving directed payments, as it streamlines the timeline for assessing coverage. The bill's key provision is the specific deadline adjustment in TCA Title 71, Chapter 5, Section 71-5-2005(d)(2)(D). The bill became law as Public Chapter 115 on April 8, 2025.
HB 584 extends the expiration date of Tennessee's annual limit on new nursing home beds from June 30, 2025, to June 30, 2029. The bill maintains the current cap of 125 new nursing home beds per fiscal year that the Health Facilities Commission can approve through its certificate of need process. This change directly affects nursing home operators seeking to expand their facilities and the commission responsible for reviewing such requests. The bill does not alter the 125-bed limit but only extends the period during which it remains in effect.
HB 395, the "Tennessee Genomic Security and End Organ Harvesting Act," prohibits Tennessee health insurers from covering organ transplants or post-transplant care if the organ was sourced from China or procured through sale/donation originating in China. It also bans medical and research facilities from using genetic sequencing equipment or software produced by entities linked to "foreign adversaries" (specifically targeting China per the bill's context), requiring replacement within 180 days. Additionally, the bill mandates that all genetic sequencing data must be stored within the United States, with remote access from outside the country prohibited without approval from the state health commissioner. The law takes effect on January 1, 2026, directly affecting health insurers, hospitals, and research facilities operating in Tennessee.
